Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 3

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Mechanism of Epigallocatechin-3-gallate in the prevention and treatment of irritable bowel syndrome: A network pharmacology and gene expression omnibus chip data-based study

Ye, Fangchen, Li, Laifu, Wang, Lianli, Ran, Yan, Mei, Lin, Sun, Yating, Zhang, Xinping, Dai, Fei·2025·PharmaNutrition
DOI 10.1016/j.phanu.2025.100433
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.phanu.2025.100433

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 44

  1. Abreu, 2010, Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function, Nat. Rev. Immunol., 10, 131, 10.1038/nri2707 · DOI · Paper page
  2. Azambuja, 2022, Protective effect of green tea and epigallocatechin-3-gallate in a LPS-induced systemic inflammation model, J. Nutr. Biochem, 101, 10.1016/j.jnutbio.2021.108920 · DOI
  3. Barbalho, 2019, Green tea: a possibility in the therapeutic approach of inflammatory bowel diseases?: Green tea and inflammatory bowel diseases, Complement Ther. Med, 43, 148, 10.1016/j.ctim.2019.01.015 · DOI
  4. Bashashati, 2014, Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis, Neurogastroenterol. Motil., 26, 1036, 10.1111/nmo.12358 · DOI
  5. Bennet, 2016, Global cytokine profiles and association with clinical characteristics in patients with irritable bowel syndrome, Am. J. Gastroenterol., 111, 1165, 10.1038/ajg.2016.223 · DOI
  6. Bradley, 2008, TNF-mediated inflammatory disease, J. Pathol., 214, 149, 10.1002/path.2287 · DOI · Paper page
  7. Brint, 2011, Differential expression of toll-like receptors in patients with irritable bowel syndrome, Am. J. Gastroenterol., 106, 329, 10.1038/ajg.2010.438 · DOI · Paper page
  8. Bruckner, 2012, Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis, J. Crohns Colitis, 6, 226, 10.1016/j.crohns.2011.08.012 · DOI
  9. Cai, 2021, Epigallocatechin-3 gallate regulates macrophage subtypes and immunometabolism to ameliorate experimental autoimmune encephalomyelitis, Cell Immunol., 368, 10.1016/j.cellimm.2021.104421 · DOI
  10. Campmans-Kuijpers, 2021, Food and food groups in inflammatory bowel disease (IBD): the design of the groningen anti-inflammatory diet (GrAID), Nutrients, 13, 10.3390/nu13041067 · DOI
  11. Chen, 2012, Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome, BMC Gastroenterol., 12, 91, 10.1186/1471-230X-12-91 · DOI
  12. Chikara, 2018, Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment, Cancer Lett., 413, 122, 10.1016/j.canlet.2017.11.002 · DOI · Paper page
  13. Eng, 2018, Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases, J. Ethnopharmacol., 210, 296, 10.1016/j.jep.2017.08.035 · DOI
  14. Gaggia, 2018, Kombucha beverage from green, black and rooibos teas: a comparative study looking at microbiology, chemistry and antioxidant activity, Nutrients, 11, 10.3390/nu11010001 · DOI
  15. Gao, 2022, Mucosal serotonin reuptake transporter expression in irritable bowel syndrome is modulated by gut microbiota via mast cell-prostaglandin E2, Gastroenterology, 162, 1962, 10.1053/j.gastro.2022.02.016 · DOI
  16. Gomes, 2023, Innovative approaches for food: using natural phenolic-rich extracts to produce value-added fresh pasta, Int. J. Mol. Sci., 24, 10.3390/ijms241512451 · DOI
  17. Grabauskas, 2020, Prostaglandin E(2), produced by mast cells in colon tissues from patients with irritable bowel syndrome, contributes to visceral hypersensitivity in mice, Gastroenterology, 158, 2195, 10.1053/j.gastro.2020.02.022 · DOI
  18. Hinojosa-Nogueira, 2021, Green and white teas as health-promoting foods, Food Funct., 12, 3799, 10.1039/D1FO00261A · DOI
  19. Hopkins, 2008, Network pharmacology: the next paradigm in drug discovery, Nat. Chem. Biol., 4, 682, 10.1038/nchembio.118 · DOI · Paper page
  20. Kumar, 2022, Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines, Clin. J. Gastroenterol., 15, 1, 10.1007/s12328-021-01555-8 · DOI
  21. Laino, 2016, Immunoregulatory effects triggered by lactic acid bacteria exopolysaccharides: new insights into molecular interactions with host cells, Microorganisms, 4, 10.3390/microorganisms4030027 · DOI
  22. Liu, 2021, Evidence from comparative genomic analyses indicating that Lactobacillus-mediated irritable bowel syndrome alleviation is mediated by conjugated linoleic acid synthesis, Food Funct., 12, 1121, 10.1039/D0FO02616F · DOI
  23. Lu, 2023, Integrated omics analysis reveals the epigenetic mechanism of visceral hypersensitivity in IBS-D, Front Pharm., 14
  24. McKernan, 2011, Altered peripheral toll-like receptor responses in the irritable bowel syndrome, Aliment Pharm. Ther., 33, 1045, 10.1111/j.1365-2036.2011.04624.x · DOI
  25. Melguizo-Rodriguez, 2021, Potential effects of phenolic compounds that can be found in olive oil on wound healing, Foods, 10, 10.3390/foods10071642 · DOI
  26. Oz, 2013, Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models, Front Immunol., 4, 132, 10.3389/fimmu.2013.00132 · DOI
  27. Pastoriza, 2017, Healthy properties of green and white teas: an update, Food Funct., 8, 2650, 10.1039/C7FO00611J · DOI · Paper page
  28. Pastoriza, 2017, Characterization of commercial Spanish non-citrus juices: antioxidant and physicochemical aspects, Food Res Int, 100, 216, 10.1016/j.foodres.2017.07.008 · DOI
  29. Schmulson, 2012, Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico, Am. J. Gastroenterol., 107, 747, 10.1038/ajg.2011.484 · DOI
  30. Shukla, 2015, Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis, Dig. Dis. Sci., 60, 2953, 10.1007/s10620-015-3607-y · DOI
  31. Shukla, 2018, Expression of toll-like receptors, pro-, and anti-inflammatory cytokines in relation to gut microbiota in irritable bowel syndrome: the evidence for its micro-organic basis, J. Neurogastroenterol. Motil., 24, 628, 10.5056/jnm18130 · DOI
  32. Staudacher, 2021, Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials, Lancet Gastroenterol. Hepatol., 6, 401, 10.1016/S2468-1253(20)30363-0 · DOI
  33. Vara, 2018, Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue, Int J. Gen. Med, 11, 285, 10.2147/IJGM.S166600 · DOI
  34. Wang, 2021, Network pharmacology analysis of the identification of phytochemicals and therapeutic mechanisms of paeoniae radix alba for the treatment of asthma, J. Immunol. Res, 2021, 10.1155/2021/9659304 · DOI
  35. Wu, 2023, Ethanol extract of mao jian green tea attenuates gastrointestinal symptoms in a rat model of irritable bowel syndrome with constipation via the 5-hydroxytryptamine signaling pathway, Foods, 12, 10.3390/foods12051101 · DOI · Paper page
  36. Wu, 2023, Coffee and tea intake with long-term risk of irritable bowel syndrome: a large-scale prospective cohort study, Int J. Epidemiol., 52, 1459, 10.1093/ije/dyad024 · DOI
  37. Xiong, 2020, Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools, Eur. J. Integr. Med, 40, 10.1016/j.eujim.2020.101241 · DOI
  38. Yan, 2022, Network pharmacology combined with metabolomics and lipidomics to reveal the hypolipidemic mechanism of Alismatis rhizoma in hyperlipidemic mice, Food Funct., 13, 4714, 10.1039/D1FO04386B · DOI
  39. Yang, 2022, Sustained Inflammation Induced by LPS Leads to Tolerable Anorexia and Fat Loss via Tlr4 in Mice, J. Inflamm. Res, 15, 5635, 10.2147/JIR.S358518 · DOI
  40. Yao, 2020, Integrating traditional Chinese medicines into professional community pharmacy practice in China - Key stakeholder perspectives, Eur. J. Integr. Med, 34, 10.1016/j.eujim.2020.101063 · DOI
  41. Zeng, 2021, Network pharmacology-based analysis of Zukamu granules for the treatment of COVID-19, Eur. J. Integr. Med, 42, 10.1016/j.eujim.2020.101282 · DOI
  42. Zheng, 2023, Qi Gong Wan ameliorates adipocyte hypertrophy and inflammation in adipose tissue in a PCOS mouse model through the Nrf2/HO-1/Cyp1b1 pathway: Integrating network pharmacology and experimental validation in vivo, J. Ethnopharmacol., 301, 10.1016/j.jep.2022.115824 · DOI
  43. Zhou, 2023, Protective effects of Liupao tea against high-fat diet/cold exposure-induced irritable bowel syndrome in rats, Heliyon, 9, 10.1016/j.heliyon.2023.e16613 · DOI
  44. Zhuang, 2020, Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?, Eur. J. Integr. Med, 37, 10.1016/j.eujim.2020.101139 · DOI

Cited by

Metadata

Authors
Ye, F., Li, L., Wang, L., Ran, Y., Mei, L., Sun, Y., Zhang, X., & Dai, F.
Venue
PharmaNutrition
Publisher
Elsevier BV
Published
2025-03
Volume
31
Pages
100433
ISSN
2213-4344
DOI
10.1016/j.phanu.2025.100433
Cited by
3
References
7
Language
en
Licence
Funders
  • Shaanxi Province Key Research and Development Projects (S2023-YF-YBSF-1670)
  • Northwestern University
  • National Natural Science Foundation of China (81770540)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.